Event-Driven Stocks

biote Corp.

BTMDNasdaq

Healthcare · Medicinal Chemicals & Botanical Products · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 3 good● 2 warning● 3 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$192.2M$197.2M$185.4M$165.0M$139.4M—
Operating income$35.6M$31.6M$28.7M−$60.7M−$3.3M$0
Net income$27.0M$3.2M$3.3M−$969,000$11.1M$0
Total assets$107.6M$122.4M$155.3M$111.6M$318.0M$147,500
Total liabilities$158.0M$224.6M$191.8M$169.9M$23.2M$122,500
Equity−$58.5M−$105.9M−$29.4M−$44.5M−$22.6M$0
EPS (diluted)$0.74$0.09$0.13$-0.12——
Shares out.36.7M34.3M25.7M58.2M——

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
18.5%
Net margin
14.1%
Return on equity
−46.2%
Return on assets
25.1%
Return on capital (ROCE)
56.8%
Liabilities / assets
146.8%
Debt / equity
—
Book value / share
$-1.60
Revenue growth (YoY)
−2.5%
Net income growth (YoY)
756.7%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
0.92distress
Accruals / assets
−7.6%clean
Piotroski F-Score
7/9strong

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
64
/ 100
Profitability 80Growth 50Catalyst 67Earnings quality 100Financial strength 25

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 3 severe● 2 warning● 3 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Revenue declined year-over-year
  • High leverage (liabilities > 70% of assets)
  • Operating margin is positive
  • Positive operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20261.6M7.1+9.5%
Apr 30, 20261.5M9.5-12.1%
Apr 15, 20261.7M4.6+6.0%
Mar 31, 20261.6M4.8-0.3%
Mar 13, 20261.6M5.7+10.8%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (4)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.